Additional data from these samples indicate increased gene expression for TNFR1 and IL6R in IUGR myoblasts and semitendinosus muscle, as well as reduced muscle IκBα protein content and increased c-Fos protein content (Posont, 2019). The gene discussed is TNFRSF1A; the disease is fetal growth restriction.